Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes
NCT05631119 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2023-10-03
Summary
The Investigators will generate a repository of human biosamples across therapeutic areas that will be used to identify disease-associated biomarkers and potential targets with immune and multi-omics profiling. This sample collection and analysis from people living with type 2 diabetes, or chronic or diabetic kidney disease will lay the groundwork for an extensive network of biosample access and linked datasets that will provide an invaluable resource for translational research.
Conditions
- Diabetic Kidney Disease
- Diabetes Type 2
- Chronic Kidney Diseases
- Healthy
Sponsors & Collaborators
- collaborator INDUSTRY
-
Sanguine Biosciences
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-15
- Primary Completion
- 2023-08-23
- Completion
- 2023-08-23
Countries
- United States
Study Locations
More Related Trials
-
To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients
NCT01069926 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated
NCT03550378 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease
NCT05687890 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
NCT03795389 ·Status: COMPLETED ·Phase: PHASE1
-
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
NCT05378282 ·Status: COMPLETED
-
Evaluating Comparative Effectiveness of Empagliflozin in Type 2 Diabetes Population With and Without Chronic Kidney Disease
NCT05465317 ·Status: COMPLETED
-
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
NCT07187479 ·Status: RECRUITING ·Phase: NA
-
A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease
NCT03270956 ·Status: COMPLETED ·Phase: PHASE2
-
Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)
NCT05018416 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
NCT01487109 ·Status: COMPLETED ·Phase: PHASE2
-
Diabetic Patients With End-Stage Renal Disease
NCT00435786 ·Status: COMPLETED
-
The Family Investigation of Nephropathy and Diabetes Study
NCT00301249 ·Status: COMPLETED
-
A Research Study Looking Into Blood Levels of the Medicine NNC0480-0389 in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function
NCT05015894 ·Status: COMPLETED ·Phase: PHASE1
-
STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT
NCT04616027 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011)
NCT05656040 ·Status: COMPLETED ·Phase: PHASE1
-
The Incretin Effect in Patients With Kidney Impairment
NCT01327378 ·Status: COMPLETED
-
A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function
NCT00501462 ·Status: COMPLETED ·Phase: PHASE1
-
CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)
NCT04990427 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function
NCT06559527 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
NCT05822609 ·Status: RECRUITING ·Phase: PHASE2
-
SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Four European Countries Using Real-world Data
NCT06769646 ·Status: COMPLETED
-
Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
NCT01549769 ·Status: TERMINATED ·Phase: PHASE1
-
Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy
NCT05695573 ·Status: COMPLETED
-
Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects
NCT01068756 ·Status: TERMINATED ·Phase: PHASE1
-
A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
NCT01572610 ·Status: TERMINATED ·Phase: PHASE2